Abbott plans to reopen and produce formula in 2 weeks

Abbott plans to reopen and produce formula in 2 weeks

Abbott plans to reopen and produce formula in 2 weeks

GRAND RAPIDS, Mich. (WOOD) — Abbott Laboratories is speaking out against the White House over the national infant formula shortage and the closure of its manufacturing plant in Sturgis.

In a Friday White House press conference, spokeswoman Jennifer Psaki noted that the formula shortage was partly caused by the closure of the Sturgis plant. “But we believe the best step we can take is to work with Abbott, and Abbott also has a responsibility to work closely with the FDA and take the necessary steps to get back and be operational online.”

The Food and Drug Administration (FDA) closed the Sturgis facility in February after a cluster of infant hospitalizations, including two infant deaths, due to a rare bacterial infection.

Abbott published a series of 11 tweets, the former saying, “At the White House press conference today, the press secretary mistakenly said that our formulas were contaminated and had killed two infants. The death of these children is a tragedy.

Abbott’s tweets argued that FDA and CDC investigations found no evidence that his formulas caused childhood illnesses.

Abbott also tweeted that “Genetic sequencing on the two available samples from sick infants did not match Cronobacter strains in our facility. The samples from sick infants did not match, meaning there was no link between the two cases. And, “in all four cases, the state, FDA, and/or CDC tested samples of the Abbott formula used by the child. In all four cases, all unopened containers tested negative. »

A statement on Abbott’s website notes that the Sturgis plant may restart operations shortly, “…we have been working to address 483 observations from the FDA so that we can restart operations at the Sturgis, Michigan facility. We immediately began implementing corrective actions and subject to FDA approval, we were able to restart our Sturgis, Michigan site within two weeks.

Abbott has ramped up infant formula production at its FDA-registered plants in Ireland and Columbus, Ohio.

#Abbott #plans #reopen #produce #formula #weeks

Tags: , , , , ,

Leave a Reply

Your email address will not be published.